1od7 | pdb_00001od7

From Proteopedia
Revision as of 18:45, 29 October 2007 by OCA (talk | contribs) (New page: left|200px<br /> <applet load="1od7" size="450" color="white" frame="true" align="right" spinBox="true" caption="1od7, resolution 3.00Å" /> '''N-TERMINAL OF SIALO...)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigationJump to search

N-TERMINAL OF SIALOADHESIN IN COMPLEX WITH ME-A-9-N-(NAPHTHYL-2-CARBONYL)-AMINO-9-DEOXY-NEU5AC (NAP COMPOUND)

File:1od7.gif


1od7, resolution 3.00Å

Drag the structure with the mouse to rotate

Overview

The Siglec family of receptors mediates cell surface interactions through, recognition of sialylated glycoconjugates. The crystal structure of the, N-terminal immunoglobulin-like domain of the Siglec sialoadhesin (SnD1) in, complex with 2,3-sialyllactose has informed the design of sialic acid, analogs (sialosides) that bind Siglecs with significantly enhanced, affinities and specificities. Binding assays against sialoadhesin (Sn;, Siglec-1), CD22 (Siglec-2), and MAG (Siglec-4) show a 10- to 300-fold, reduction in IC(50) values (relative to methyl-alpha-Neu5Ac) for three, sialosides bearing aromatic group modifications of the glycerol side, chain: Me-alpha-9-N-benzoyl-amino-9-deoxy-Neu5Ac (BENZ), Me-alpha-9-N-(naphthyl-2-carbonyl)-amino-9-deoxy-Neu5Ac (NAP), and, ... [(full description)]

About this Structure

1OD7 is a [Single protein] structure of sequence from [Mus musculus] with SUW as [ligand]. Full crystallographic information is available from [OCA].

Reference

Structure-guided design of sialic acid-based Siglec inhibitors and crystallographic analysis in complex with sialoadhesin., Zaccai NR, Maenaka K, Maenaka T, Crocker PR, Brossmer R, Kelm S, Jones EY, Structure. 2003 May;11(5):557-67. PMID:12737821

Page seeded by OCA on Mon Oct 29 20:50:23 2007

Proteopedia Page Contributors and Editors (what is this?)

OCA